Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bertha Knoll is active.

Publication


Featured researches published by Bertha Knoll.


Physiology & Behavior | 1996

Differences in some behavioural effects of deprenyl and amphetamine enantiomers in rats

Julia Timár; Zsuzsanna Gyarmati; László Barna; Bertha Knoll

Effects of deprenyl and amphetamine enantiomers on different behavioural patterns were compared. Whereas (+)-amphetamine in doses of 1-3 mg/kg SC, (-)-amphetamine, and (+)-deprenyl in doses of 5-20 mg/kg SC increased the locomotor activity and the time the animals displayed stereotyped head movement, enhanced the acquisition of conditioned avoidance responses, and developed positive place preference conditioning, (-)-deprenyl, even in as high a dose as 20 mg/kg SC, failed to show any amphetamine-type behavioural effect. The results provide further proof why (-)-deprenyl, in contrast to other members of the amphetamine family, can be considered as a safe drug.


Physiology & Behavior | 1985

The anorectic effect of satietin is unrelated to carbohydrate metabolism

Susanna Gyarmati; J. Földes; L. Korányi; Bertha Knoll; J. Knoll

The effect of satietin and amphetamine on the carbohydrate metabolism of free fed and food deprived rats was studied. Rats deprived of food for 96 hours maintained normal glucose and glucagon blood levels but the blood concentration of insulin dropped from 232.02 +/- 23.93 to 12.48 +/- 0.71 pmol/l. Amphetamine (500 micrograms/animal, intracerebroventricularly) left in normally fed rats the blood concentration of glucose, insulin and glucagon unchanged. The same treatment, however, increased the insulin concentration in the blood of food deprived rats from 11.37 +/- 4.43 to 73.47 +/- 8.29 pmol/l. Glucose and glucagon, as well as insulin levels remained unchanged in both normally fed and food deprived rats when treated with satietin (20 micrograms/rat, intracerebroventricularly). It was concluded that the anorectic effect of satietin is unrelated to carbohydrate metabolism.


Catecholamines: Basic and Clinical Frontiers#R##N#Proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, California, September 17-22, 1978 | 1979

THE TYPE OF MAO IN THE NIGROSTRIATAL DOPAMINERGIC NEURONS OF THE RAT

Bertha Knoll; Julia Timár

Clorgyline, the selective inhibitor of MAO A counteracts the effect of the substantia nigra (SN) lesion, while (-)deprenyl, the selective inhibitor of MAO B proved to be ineffective showing that type A is the functionally important form of MAO in the nigrostriatal dopaminergic neurons of rat.


Synaptic Constituents in Health and Disease#R##N#Proceedings of the Third Meeting of the European Society for Neurochemistry, Bled, August 31st to September 5th, 1980 | 1980

SATIETIN: A HIGHLY POTENT ANOREXOGENIC SUBSTANCE IN MAMMALIAN BLOOD

Bertha Knoll; H. Kalász

Publisher Summary This chapter focuses a substance named satietin that is capable of reducing food intake drastically in rats deprived of food for 96 h, which was discovered in human serum and detected in the blood of different species. Highly purified satietin samples extracted from human serum showing one band only in polyacrylamide gelelectrophoresis, containing in average 60.6% amino acids and 13.5% carbohydrates, were used for biological experiments. The intracerebroventricular injection of 10–100 μg satietin 5 h before the test meal decreased food consumption drastically and in a dose-dependent manner. The satietin-like long lasting inhibition of food intake seems to be unique.


Archives internationales de pharmacodynamie et de thérapie | 1992

The pharmacology of 1-phenyl-2-propylamino-pentane (PPAP), a deprenyl-derived new spectrum psychostimulant

Bertha Knoll; Török Z; Julia Timár; Yasar S


Archives internationales de pharmacodynamie et de thérapie | 1986

Long-term administration of (−)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged

Julia Timár; Bertha Knoll


Acta Physiologica Hungarica | 1992

(-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats

Julia Timár; Bertha Knoll


European Journal of Pharmacology | 1990

1-phaenyl-2-propyl-aminopentane. HCl (MK-306): A deprenyl-derived new spectrum psychostimulant

Bertha Knoll; Yasar S; I. Faragó; Illés Kovács


Monoamine Oxidases and their Selective Inhibition#R##N#Proceedings of the 3rd Congress of the Hungarian Pharmacological Society, Budapest, 1979 | 1980

MONOAMINE OXIDASE INHIBITORS (MAOIs) AND FOOD INTAKE

Bertha Knoll


Pharmacological Research | 1995

Some behavioral effects of P-fluordeprenyl enantiomers is rats

Julia Timár; S. Gyarmati; L. Barna; Bertha Knoll

Collaboration


Dive into the Bertha Knoll's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasar S

Semmelweis University

View shared research outputs
Top Co-Authors

Avatar

J. Knoll

Semmelweis University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E.S. Vizi

Semmelweis University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge